ORIGINAL RESEARCH article

Front. Surg.

Sec. Orthopedic Surgery

Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1415680

Prediction of 1-year post operative mortality in elderly patients with fragility hip fractures in China: evaluation of risk prediction models

Provisionally accepted
Qiyuan  LuQiyuan Lu1Houfu  LingHoufu Ling2*
  • 1Yuyao Hospital of Traditional Chinese Medicine, Ningbo, China
  • 2First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China

The final, formatted version of the article will be published soon.

This study systematically evaluates the predictive capacity of seven risk stratification models for 12-month postoperative mortality in geriatric patients with fragility hip fractures, while concurrently assessing their risk classification accuracy to inform perioperative protocol formulation, rehabilitation strategies, and prognostic management.Current clinical practice lacks standardized criteria for mortality risk prediction in elderly fragility hip fracture patients. This investigation conducts a comparative evaluation of seven prognostic models -the Sernbo Score, Jiang et al. model, Nottingham Hip Fracture Score (NHFS), Holt et al. algorithm, HEMA, ASAgeCoGeCC Score, and SHiPS-to determine their discriminative performance and risk stratification efficacy in predicting 12-month postoperative mortality.Methods In this retrospective cohort analysis, all consecutive patients aged ≥65 years diagnosed with fragility hip fractures between January 2018 and October 2022 were enrolled. Model-derived mortality predictions and risk categorizations were computed. Predictive performance was quantified through the predictive validity, the area under the receiver operating characteristic (ROC) curve (AUC) analysis , DeLong test, Hosmer-Lemeshow goodness-of-fit testing and calibration slope (95% CI), followed by precision assessment of risk stratification tiers.The cohort demonstrated a 12-month mortality rate of 29.0%. Kaplan-Meier survival curves identified the first postoperative year as the highest mortality risk period. The ASAgeCoGeCC Score was the only model in this study that simultaneously demonstrated balanced sensitivity (0.73)/specificity (0.82), excellent discrimination (AUC=0.84), and good calibration (H-L p=0.36, calibration slope=0.75). The DeLong test indicated its significantly superior performance compared to the other models (p < 0.01). The NHFS and Holt et al. performed next best. All models except the Sernbo Score achieved AUC values exceeding 0.70. Significant calibration deficiencies were observed in NHFS, HEMA, and SHiPS (Hosmer-Lemeshow p < 0.05). Risk stratification analysis revealed SHiPS as the most precise classification system. Conclusion ASAgeCoGeCC score, NHFS and Holt et al.showed acceptable predictive performance,where the first two are applicable to clinical rapid decision-making, while NHFS has been extensively external validated. Holt et al.is more suitable for a well-resourced medical system. SHiPS displayed optimal risk categorization accuracy, suggesting potential for broader clinical implementation. These findings necessitate verification through prospective multi-center studies.

Keywords: Fragility hip fracture, Mortality, risk prediction, risk stratification, NHFS

Received: 11 Apr 2024; Accepted: 05 Jun 2025.

Copyright: © 2025 Lu and Ling. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Houfu Ling, First Affiliated Hospital, Zhejiang Chinese Medical University, Hangzhou, 310003, Zhejiang Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.